- Lifeist’s (LFST) subsidiary, Mikra Cellular Sciences Inc., plans to launch its second consumer product RESCUE, in mid-December
- RESCUE is a 100 per cent naturally derived and rapid-acting digestive aid
- Mikra is a biosciences and consumer wellness company bringing to market innovative therapies for cellular health
- Lifeist leverages advancements in science and technology to build breakthrough companies that transform human wellness
- Lifeist Wellness Inc. (LFST) opened trading at $0.075 per share
Lifeist’s (LFST) subsidiary, Mikra Cellular Sciences, plans to launch its second consumer product RESCUE, in mid-December.
RESCUE is a 100 per cent naturally derived and rapid-acting digestive aid. Each dose contains pure, fine-milled activated coconut charcoal powder. It is made from super-heated coconut shells, which trap the body’s toxins and chemicals within its pores.
The toxins and chemicals stick to the porous surface of the active detox element through absorption. The toxins then eliminate safely and rapidly through the body’s natural digestive and metabolic processes.
Manufactured in the United States, RESCUE is 100 per cent vegan. It is free from soy, gluten, GMOs, dairy, egg and animal products. There are no fillers, additives or alternate carbon sources. Furthermore, the packaging is fully recyclable, and the low-waste biofilm refill pouch and label are compostable.
Mikra is a biosciences and consumer wellness company bringing to market innovative therapies for cellular health.
Lifeist leverages advancements in science and technology to build breakthrough companies that transform human wellness. Its portfolio business units include CannMart, CannMart Labs, Australian Vapes, and Mikra.
Lifeist Wellness Inc. (LFST) opened trading at $0.075 per share.
